Meningitis, Cryptococcal

Known as: crypto meningitis, MENINGITIS TORULA, Cryptococcal Meningitis 
Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1954-2017
05010019542016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Jeremy N. Day, M.D., Ph.D., Tran T.H. Chau, M.D., Ph.D., Marcel Wolbers, Ph.D., Pham P. Mai, M.D., Nguyen T. Dung, M.D., Nguyen H… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Many deaths from cryptococcal meningitis (CM) may be preventable through early diagnosis and treatment. An inexpensive… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Cryptococcal meningitis is a leading cause of death in patients with acquired immunodeficiency syndrome and… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Cryptococcal meningitis (CM) is the proximate cause of death in 20%-30% of persons with acquired immunodeficiency… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND It frequently takes more than 2 weeks for drug treatments for cryptococcal meningitis to sterilise cerebrospinal fluid… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
s of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, ON, Canada). Washington, DC: American… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND Treatment with low-dose amphotericin B (0.4 mg per kilogram of body weight per day) or oral azole therapy in patients… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Intravenous amphotericin B, with or without flucytosine, is usually standard therapy for cryptococcal meningitis in… (More)
Is this relevant?
Highly Cited
1980
Highly Cited
1980
This paper describes the salient features of a new model for chronic cryptococcal meningitis in cortisone-treated rabbits. Normal… (More)
Is this relevant?
Highly Cited
1979
Highly Cited
1979
We compared amphotericin B therapy for cryptococcal meningitis with a newer regimen containing both amphotericin B and… (More)
Is this relevant?